CVE-2024-41668CWE-918

cBioPortal Proxy Endpoint Vulnerabliity

High · published July 23, 2024

CVSS v3.1
8.3
EPSS
1%
Percentile
47.0
In the wild
Unconfirmed
What it is

The cBioPortal for Cancer Genomics provides visualization, analysis, and download of large-scale cancer genomics data sets. When running a publicly exposed proxy endpoint without authentication, cBioPortal could allow someone to perform a Server Side Request Forgery (SSRF) attack. Logged in users could do the same on private instances. A fix has been released in version 6.0.12. As a workaround, one might be able to disable `/proxy` endpoint entirely via, for example, nginx.

The record
Technical detail
CVSS v3.1
8.3 · HIGH
Vector
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:L/I:L/A:L
CVSS v4.0
Not supplied
EPSS
0.00580 · 47.0th percentile
Weakness
CWE-918 · Server-Side Request Forgery (SSRF)
Published
2024-07-23T18:14Z
EPSS history
Timeline
  • 23 JUL 18:14Z
    cBioPortal Proxy Endpoint Vulnerabliity
    cvelistv5